Skip to main content
. Author manuscript; available in PMC: 2015 Oct 24.
Published in final edited form as: Ann Surg. 2012 Aug;256(2):350–356. doi: 10.1097/SLA.0b013e318256d1f5

TABLE 1.

Patient Characteristics

No. %
Total 97
Age Median 67 (33–68)
Sex
 Male 48 49
 Female 49 51
Stage
 Unknown 4 4
 IIIB 61 63
 IIIC 29 30
 IV 3 3
Stage IIIC/IV resected peri-ILI 10 10
M-ILI + ADH-1 trial 22 23
M-ILI + sorafenib trial 6 6
Previous regional chemotherapy 4 4